LoginRegister
    Cadila Healthcare largest API manufacturing site clears USFDA inspectionCadila Healthcare largest API manufacturing site clears USFDA inspection
    Eli Lilly migraine drug Lasmiditan wins USFDA approvalEli Lilly migraine drug Lasmiditan wins USFDA approval
    GSK collaborates with Lyell Immunopharma on cancer cell therapiesGSK collaborates with Lyell Immunopharma on cancer cell therapies
    OxyContin maker Purdue Pharma seeks to halt opioid lawsuitsOxyContin maker Purdue Pharma seeks to halt opioid lawsuits
    Accused of Swindling lakhs of rupees, Pharma sales representative hangs selfAccused of Swindling lakhs of rupees, Pharma sales representative hangs self
    Aurobindo Pharma Unit-7 documents inaccurate, misleading: USFDAAurobindo Pharma Unit-7 documents inaccurate, misleading: USFDA
    Biocon arm signs licensing agreement with Evotec for biosimilar assetBiocon arm signs licensing agreement with Evotec for biosimilar asset
    Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque PsoriasisSun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis
    Bayer inks deals with 11 startups under G4A to develop new digital health solutionsBayer inks deals with 11 startups under G4A to develop new digital health solutions
    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facilityTorrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility
    Dr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical AllianceDr Reddys Chairman Satish Reddy named as New President of Indian Pharmaceutical Alliance
    Aurobindo Pharma rises 5 pc post clarification on USFDA observations for Unit-7Aurobindo Pharma rises 5 pc post clarification on USFDA observations for Unit-7
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X